Prevalence of and factors associated with herpes zoster in England: a cross-sectional analysis of the Health Survey for England.
Herpes zoster
Prevalence
Risk factor
Shingles
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
01 Jun 2022
01 Jun 2022
Historique:
received:
08
03
2022
accepted:
16
05
2022
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Herpes zoster (commonly called shingles) is caused by the reactivation of varicella zoster virus, and results in substantial morbidity. While the risk of zoster increases significantly with age and immunosuppression, relatively little is known about other risk factors for zoster. Moreover, much evidence to date stems from electronic healthcare or administrative data. Hence, the aim of this study was to explore potential risk factors for herpes zoster using survey data from a nationally-representative sample of the general community-dwelling population in England. Data were extracted from the 2015 Health Survey for England, an annual cross-sectional representative survey of households in England. The lifetime prevalence of self-reported herpes zoster was described by age, gender and other socio-demographic factors, health behaviours (physical activity levels, body mass index, smoking status and alcohol consumption) and clinical conditions, including; diabetes, respiratory, digestive and genito-urinary system and mental health disorders. Logistic regression models were then used to identify possible factors associated with shingles, and results were presented as odds ratios with 95% confidence intervals. The lifetime prevalence of shingles among the sample was 11.5% (12.6% among women, 10.3% among men), which increased with age. After adjusting for a range of covariates, increased age, female gender (odds ratio: 1.21; 95%CI: 1.03, 1.43), White ethnic backgrounds (odds ratio: 2.00; 95%CI: 1.40, 2.88), moderate physical activity 7 days per week (odds ratio: 1.29; 95%CI: 1.01, 1.66) and digestive disorders (odds ratio: 1.51; 95%CI: 1.13, 1.51) were each associated with increased odds of having had herpes zoster. Age, gender, ethnicity and digestive disorders may be risk factors for herpes zoster among a nationally representative sample of adults in England. These potential risk factors and possible mechanisms should be further explored using longitudinal studies.
Sections du résumé
BACKGROUND
BACKGROUND
Herpes zoster (commonly called shingles) is caused by the reactivation of varicella zoster virus, and results in substantial morbidity. While the risk of zoster increases significantly with age and immunosuppression, relatively little is known about other risk factors for zoster. Moreover, much evidence to date stems from electronic healthcare or administrative data. Hence, the aim of this study was to explore potential risk factors for herpes zoster using survey data from a nationally-representative sample of the general community-dwelling population in England.
METHODS
METHODS
Data were extracted from the 2015 Health Survey for England, an annual cross-sectional representative survey of households in England. The lifetime prevalence of self-reported herpes zoster was described by age, gender and other socio-demographic factors, health behaviours (physical activity levels, body mass index, smoking status and alcohol consumption) and clinical conditions, including; diabetes, respiratory, digestive and genito-urinary system and mental health disorders. Logistic regression models were then used to identify possible factors associated with shingles, and results were presented as odds ratios with 95% confidence intervals.
RESULTS
RESULTS
The lifetime prevalence of shingles among the sample was 11.5% (12.6% among women, 10.3% among men), which increased with age. After adjusting for a range of covariates, increased age, female gender (odds ratio: 1.21; 95%CI: 1.03, 1.43), White ethnic backgrounds (odds ratio: 2.00; 95%CI: 1.40, 2.88), moderate physical activity 7 days per week (odds ratio: 1.29; 95%CI: 1.01, 1.66) and digestive disorders (odds ratio: 1.51; 95%CI: 1.13, 1.51) were each associated with increased odds of having had herpes zoster.
CONCLUSIONS
CONCLUSIONS
Age, gender, ethnicity and digestive disorders may be risk factors for herpes zoster among a nationally representative sample of adults in England. These potential risk factors and possible mechanisms should be further explored using longitudinal studies.
Identifiants
pubmed: 35650527
doi: 10.1186/s12879-022-07479-z
pii: 10.1186/s12879-022-07479-z
pmc: PMC9158364
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
513Subventions
Organisme : Wellcome Trust
ID : 201440/Z/16/Z
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Mayo Clin Proc. 2007 Nov;82(11):1341-9
pubmed: 17976353
Open Forum Infect Dis. 2016 Jun 11;3(3):ofw119
pubmed: 27382600
Lancet Neurol. 2007 Nov;6(11):1015-28
pubmed: 17945155
Dermatology. 2021;237(6):891-895
pubmed: 33326962
Int J Epidemiol. 2012 Dec;41(6):1585-93
pubmed: 22253315
BMJ. 2014 May 13;348:g2911
pubmed: 25134101
Ann Epidemiol. 2016 Jun;26(6):441-446.e3
pubmed: 27180114
Epidemiol Infect. 2009 Jan;137(1):38-47
pubmed: 18466661
Am J Epidemiol. 2021 Jun 1;190(6):1064-1074
pubmed: 33569573
Epidemiol Infect. 2004 Jan;132(1):1-5
pubmed: 14979582
Exerc Immunol Rev. 2011;17:6-63
pubmed: 21446352
N Engl J Med. 1996 Jul 4;335(1):32-42
pubmed: 8637540
Mayo Clin Proc. 2012 Oct;87(10):961-7
pubmed: 23036671
Indian J Dermatol. 2008;53(3):119-21
pubmed: 19882008
Clin Infect Dis. 2011 Feb 1;52(3):332-40
pubmed: 21217180
Lancet Infect Dis. 2004 Jan;4(1):26-33
pubmed: 14720565
Open Forum Infect Dis. 2020 Jan 09;7(1):ofaa005
pubmed: 32010734
BMJ Open. 2014 Jun 10;4(6):e004833
pubmed: 24916088
CMAJ. 2011 Mar 22;183(5):E275-80
pubmed: 21343261
J Am Board Fam Med. 2013 Jan-Feb;26(1):45-51
pubmed: 23288280
J Clin Epidemiol. 1994 Nov;47(11):1271-6
pubmed: 7722563
Vaccine. 2018 Mar 14;36(12):1537-1541
pubmed: 29463421
Epidemiol Infect. 2015 Oct;143(13):2871-81
pubmed: 25592769
Ann Epidemiol. 2006 Sep;16(9):692-5
pubmed: 16516488
Clin Infect Dis. 2021 Nov 2;73(9):e3210-e3217
pubmed: 32829399
Hum Vaccin Immunother. 2017 Nov 2;13(11):2606-2611
pubmed: 28933622
J Trop Med Hyg. 1963 Dec;66:311-5
pubmed: 14090785
Infection. 2008 Jun;36(3):226-30
pubmed: 18454342
J Gen Intern Med. 2005 Aug;20(8):748-53
pubmed: 16050886
N Engl J Med. 2002 Aug 1;347(5):340-6
pubmed: 12151472
Aliment Pharmacol Ther. 2013 Feb;37(4):420-9
pubmed: 23240738
J Infect Dis. 1998 Nov;178 Suppl 1:S67-70
pubmed: 9852978
Vaccine. 2009 Feb 25;27(9):1454-67
pubmed: 19135492
Mayo Clin Proc. 2017 Dec;92(12):1806-1821
pubmed: 29202939
BMC Infect Dis. 2011 Jun 16;11:173
pubmed: 21679419
BMC Infect Dis. 2010 Aug 03;10:230
pubmed: 20682044